The Prognostic Value of Alpha-Fetoprotein Response for Advanced-Stage Hepatocellular Carcinoma Treated with Sorafenib Combined with Transarterial Chemoembolization

The Prognostic Value of Alpha-Fetoprotein Response for Advanced-Stage Hepatocellular Carcinoma Treated with Sorafenib Combined with Transarterial Chemoembolization

This retrospective cohort study aimed to evaluate the prognostic value of the alpha-fetoprotein (AFP) response in advanced-stage hepatocellular carcinoma (HCC) patients treated with sorafenib combined with transarterial chemoembolization. From May 2008 to July 2012, 118 HCC patients with baseline AF...

Full description

Bibliographic Details
Main Authors: Liu, Lei, Zhao, Yan, Jia, Jia, Chen, Hui, Bai, Wei, Yang, Man, Yin, Zhanxin, He, Chuangye, Zhang, Lei, Guo, Wengang, Niu, Jing, Yuan, Jie, Cai, Hongwei, Xia, Jielai, Fan, Daiming, Han, Guohong
Format: Online
Language:English
Published: Nature Publishing Group 2016
Online Access:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4735679/

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4735679/

Similar Items